March 23, 2023
Low bone mineral density (BMD), particularly at the femoral neck, emerged as a “robust” risk factor for dementia in older adults in the long-running Rotterdam Study. […]
March 23, 2023
People with epilepsy have a twofold increased risk for death compared with their counterparts without the condition, irrespective of comorbidities or disease severity, new research shows. […]
March 22, 2023
Telomere shortening — a sign of cellular aging — is associated with multiple changes in the brain associated with dementia, whereas longer telomeres associate with better […]
March 22, 2023
Restless legs syndrome (RLS) is associated with an elevated risk of dementia among older adults, suggesting the disorder may be a risk factor for dementia or […]
March 20, 2023
Fertility treatments (FTs) pose little risk of relapse in women with multiple sclerosis (MS), especially when they continue therapy, a new study shows. In a retrospective […]
March 17, 2023
WASHINGTON, March 16 (Reuters) – The Alzheimer’s Association has deployed 1,000 people diagnosed with, or caring for someone with the disease, to meet with all 535 […]
March 16, 2023
A common chemical that is used in correction fluid, paint removers, gun cleaners, aerosol cleaning products, and dry cleaning may be the key culprit behind the […]
March 16, 2023
Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes, may be a potential treatment for idiopathic intracranial hypertension (IIH). In a small […]
March 14, 2023
The US Food and Drug Administration (FDA) has approved zavegepant (Zavzpret, Pfizer), the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment […]